Learn how you can be involved.
Scleroderma is a very complicated disease that is different for different people. You can help advance the research by participating in our studies. The more details we can understand about how scleroderma affects different people in different ways the closer we can come to finding the root cause.
CONQUER Registry
CONQUER is a registry that collects data about scleroderma patients to track and analyse the health status, disease complications, treatments, and outcomes of many patients over many years.
Clinical Trials
Clinical trials are a meaningful way to get involved with research and help find a cure. Search to find trials that are relevant to you.
CONQUEST
CONQUEST is a phase 2b, international, multicenter, platform clinical trial developed by the SRF and partner biopharmaceutical companies.
CLINICAL TRIAL PARTICIPATION
Join the quest to advance systemic sclerosis research through CONQUEST.
Consider enrolling in the CONQUEST study, a scleroderma clinical trial for people with systemic sclerosis-associated interstitial lung disease (SSc-ILD). Participants help progress research to potentially uncover new SSc-ILD treatment options.
